FDA Approves Senza®, Nevro's High Frequency Spinal Cord

By A Mystery Man Writer

The Senza System has been approved by the FDA for the treatment of chronic pain associated with painful diabetic neuropathy.

FDA Approves Senza, Nevro's High Frequency Spinal Cord Stimulation Therapy For PDN - Beyond Type 1

Lauren Jensen posted on LinkedIn

Nevro receives CE mark for full-body MRI conditional labelling with the Senza system - NeuroNews International

Nevro's Spinal Cord Stimulation System Efficacious in Treating Painful Diabetic Neuropathy

MedTech News Artica, Nevro, Restore Medical, Respiree, Abbott

Carsen Messig on LinkedIn: FDA Approves Expanded Labeling for High-Frequency SCS for Nonsurgical…

Spinal Stimulation Therapy, Chronic Pain Relief

HF10 Therapy Shown Effective For Variety of Pain Conditions

Spinal Cord Stimulation OK'd for Diabetic Nerve Pain